David Rawlings
Pediatric Allergy/Immunology · Seattle, WANPI 1720164403
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $25,514 of the $29,029 with a category attached, or 87.9%. CSL Behring accounts for 74.0% of it on its own, with 1 other manufacturer making up the rest. Reporting peaked in 2021 at $11,460 and has fallen 67.3% since, to $3,750 in 2023.
Across 19 payments — averaging $1527.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- CSL Behring$21K
- Spark Therapeutics, Inc.$8K
Across 50 payments — averaging $311,315 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- CSL Behring$15.5M
- Bayer$50K
What the payments were for
- Consulting fees$25,51488%
- Travel & lodging$3,20111%
- Food & beverage$3151%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| CSL Behring | 10 | $21,485 |
| Spark Therapeutics, Inc. | 9 | $7,544 |
How this compares
Too few pediatric allergy/immunology providers in Washingtonto place this figure against a meaningful peer group, so we don't.
Other pediatric allergy/immunology in Seattle
- Hans OchsSeattle$23K
- Lauren GundermanSeattle$3K
- Maria Teresa de la MorenaSeattle$339
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.